FMTX News and Press, Forma Therapeutics Holdings Inc.

Summary Biotechs are relatively better positioned in this fourth quarter compared to the broader market. Path of interest rates is clearer for 2022 and the Fed is closer to a pause early next year as it calibrates down its response from a hammer approach. Biotechs benefit if a...

NEW YORK, NY / ACCESSWIRE / October 5, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Forma Therapeutics, Holdings Inc. ...

The “Believe it!” Campaign Will be Featured on TV Networks and Radio Stations Across the U.S., Driving Viewers to SCDBelieveIT.org The Sickle Cell Disease Association of America, Inc. (SCDAA), in partnership with Forma Therapeutics, Inc. (Nasdaq: FMTX) ...

NEW YORK, NY / ACCESSWIRE / September 27, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: EVO Payments, Inc. (NASDAQ:EVOP...

NEW YORK, NY / ACCESSWIRE / September 8, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Forma Therapeutics, Holdings Inc...

Forma Therapeutics Holdings Inc ( NASDAQ: FMTX ) shares are up 50% after announcing a definitive agreement with Novo Nordisk. According to the agreement terms, Novo Nordisk will purchase the clinical-stage pharmaceutical firm focusing on rare blood disorders and sickle cell dise...

Shares of Forma Therapeutics Holdings (NASDAQ: FMTX) were up by a healthy 49% as of 1:17 p.m. ET Thursday afternoon. The small-cap biotech's stock is roaring higher in response to a $1.1 billion buyout agreement with Danish drugmaker Novo Nordisk (NYSE: NVO) . Novo Nordi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Phonlamai Photo / Shutterstock.com Guardforce AI (NASDAQ: GFAI ) stock is climbing higher on Thursday after announcing a new executive team . The first changes are for the current CEO Lei Wang. S...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s a newsworthy morning as Novo Nordisk (NYSE: NVO ) just announced that it will acquire Forma Therapeutics (NASDAQ: FMTX ). This is a $1.1 billion deal that will allow Novo Nordisk to expand its port...

Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for $20 per share in cash, which represents a total equity value of $1.1 billion. Forma Therapeut...